These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33736932)

  • 1. Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice.
    Li B; Cheng Y; Yin Y; Xue J; Yu S; Gao J; Liu J; Zang L; Mu Y
    Cytotherapy; 2021 Jun; 23(6):510-520. PubMed ID: 33736932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
    Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control by umbilical cord-derived mesenchymal stem cells promotes effects of fasting-mimicking diet on type 2 diabetic mice.
    Zhao N; Gao YF; Bao L; Lei J; An HX; Pu FX; Cheng RP; Chen J; Ni H; Sui BD; Ji FP; Hu CH
    Stem Cell Res Ther; 2021 Jul; 12(1):395. PubMed ID: 34256832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation.
    Wang L; Liu T; Liang R; Wang G; Liu Y; Zou J; Liu N; Zhang B; Liu Y; Ding X; Cai X; Wang Z; Xu X; Ricordi C; Wang S; Shen Z
    EBioMedicine; 2020 Jan; 51():102615. PubMed ID: 31918404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermosensitive and injectable chitosan-based hydrogel embedding umbilical cord mesenchymal stem cells for β-cell repairing in type 2 diabetes mellitus.
    Yang J; Liu Y; Deng G; Feng J; Yu H; Cen X; Li H; Huang Q; Zhang H
    Int J Biol Macromol; 2024 Nov; 279(Pt 4):135546. PubMed ID: 39265905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
    Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
    Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes.
    Xue J; Gao J; Gu Y; Wang A; Yu S; Li B; Yin Y; Wang J; Su W; Zhang H; Ren W; Gu W; Lv Z; Mu Y; Cheng Y
    Stem Cell Res Ther; 2022 Mar; 13(1):109. PubMed ID: 35313972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction.
    Sun Y; Shi H; Yin S; Ji C; Zhang X; Zhang B; Wu P; Shi Y; Mao F; Yan Y; Xu W; Qian H
    ACS Nano; 2018 Aug; 12(8):7613-7628. PubMed ID: 30052036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
    Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors that influence the clinical efficacy of umbilical cord-derived mesenchymal stromal cells in the treatment of type 2 diabetes mellitus.
    Wang Y; Chen H; Li Y; Hao H; Liu J; Chen Y; Meng J; Zhang S; Gu W; Lyu Z; Zang L; Mu Y
    Cytotherapy; 2024 Mar; 26(3):311-316. PubMed ID: 38219142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Zang L; Liu J; Gao J; Xue J; Xie Z; Zhang Q; Han W; Mu Y
    Cell Death Dis; 2018 Jul; 9(7):760. PubMed ID: 29988034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
    Yu S; Cheng Y; Zhang L; Yin Y; Xue J; Li B; Gong Z; Gao J; Mu Y
    Stem Cell Res Ther; 2019 Nov; 10(1):333. PubMed ID: 31747961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes.
    Wang W; Wu RD; Chen P; Xu XJ; Shi XZ; Huang LH; Shao ZL; Guo W
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3212. PubMed ID: 31411368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.